Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paul Helft"'
Autor:
Akshan Puar, MBBS, Diane Donegan, MD, Paul Helft, MD, Matthew Kuhar, MD, Jonathan Webster, MD, Megana Rao, BS, Michael Econs, MD
Publikováno v:
AACE Clinical Case Reports, Vol 8, Iss 5, Pp 217-220 (2022)
Background/Objective: Pemigatinib, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, is a novel therapeutic approach for treating cholangiocarcinoma when an FGFR fusion or gene rearrangement is identified. Although the most reported side effe
Externí odkaz:
https://doaj.org/article/fdb3b691829b4608be1a6b6a91462fd5
Autor:
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A Thompson, Robert Graham, Maureen E Cooper, Dean C Pavlick, Lee A Albacker, Jeffery Gregg, Jeffery P Solzak, Yu-Hsiang Chen, Casey L Bales, Erica Cantor, Bradley A Hancock, Nawal Kassem, Paul Helft, Bert O'Neil, Anna Maria Storniolo, Sunil Badve, Kathy D Miller, Milan Radovich
Publikováno v:
Cancer Research. 82:PD9-10
Purpose: Patients with triple negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy (NAC) have high risk of recurrence with prior data suggesting improved outcomes with capecitabine. Targeted agents have demonstrated acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b6e07aa59291a5b928144d855484380
https://doi.org/10.1158/1538-7445.sabcs21-pd9-10
https://doi.org/10.1158/1538-7445.sabcs21-pd9-10
Autor:
Ramaswamy, Govindan, Howard, McLeod, Prasad, Mantravadi, Naomi, Fineberg, Paul, Helft, Kenneth, Kesler, Nasser, Hanna, Cindy, Stoner, Rafat, Ansari, Edward, Fox
Publikováno v:
Oncology (Williston Park, N.Y.). 18(14 Suppl 14)
Esophageal cancer frequently expresses cyclooxygenase-2 (COX-2) enzyme. In preclinical studies, COX-2 inhibition results in decreased cell proliferation and potentiation of chemotherapy and radiation. We report preliminary results of a phase II study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c11a501c96ba07f03c7003133ab5d54
https://pubmed.ncbi.nlm.nih.gov/15685829
https://pubmed.ncbi.nlm.nih.gov/15685829